Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2020-09-16 8:45 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
0 | $0 | 196,894 (Direct) |
View |
Ownership |
2020-09-16 8:44 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Forbion Capital Fund IV Cooperatief U.A. 10% Owner |
0 | $0 | 6,131,079 (Direct) |
View |
Ownership |
2020-09-16 8:44 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | CureDuchenne Ventures LLC 10% Owner |
0 | $0 | 602,972 (Direct) |
View |
Ownership |
2020-09-16 8:43 pm |
N/A 2029-09-05 |
Dyne Therapeutics Inc. | DYN | Klein Lawrence Otto Director |
0 | $0 | 69,133 (Direct) |
View |
Ownership |
2020-09-16 8:40 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | VV Manager II LLC Vida Ventures II LLC VIDA VENTURES II-A LLC 10% Owner |
0 | $0 | 2,145,046 (Indirect) |
View |
Ownership |
2020-09-16 8:39 pm |
N/A 2030-01-05 |
Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks |
0 | $0 | 157,514 (Direct) |
View |
Ownership |
2020-09-16 8:39 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Atlas Venture Fund XI L.P. Atlas Venture Associates XI LLC Atlas Venture Associates XI L.P. Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC 10% Owner |
0 | $0 | 9,748,915 (Indirect) |
View |
Ownership |
2020-09-16 8:39 pm |
N/A 2030-01-05 |
Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana See Remarks |
0 | $0 | 189,873 (Direct) |
View |
Ownership |
2020-09-16 8:38 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | Subramanian Romesh Chief Scientific Officer 10% Owner |
0 | $0 | 803,248 (Direct) |
View |